1. A multistage oral delivery system of PTX for improving oral bioavailability and enhancing anticancer efficacy.
- Author
-
Zhao T, Zhou H, Wu W, Song X, and Gong T
- Subjects
- Administration, Oral, Animals, Biological Availability, Cell Line, Tumor, Drug Carriers, Humans, Mice, Micelles, Antineoplastic Agents, Phytogenic, Caco-2 Cells chemistry, Paclitaxel
- Abstract
Objective: Bromotetrandrine (W198) was reported as a P-glycoprotein (P-gp) inhibitor. We aimed to prepare oral W198 micelles following by paclitaxel (PTX) micelles (W198/PTX micelles) to improve the clinical application of PTX., Significance: The poor water solubility, intestinal permeability, and multidrug resistance (MDR) of PTX can be improved in the multistage oral delivery system., Methods: The novel W198/PTX oral micelles were developed by water-bath ultrasound method and were evaluated in vivo and in vitro in 4T1 orthotopic tumor-bearing mice model., Results: PTX micelles and W198 micelles were prepared to be round and uniform. W198 micelles pre-administrated group showed higher cellular uptake efficiency of PTX on Caco-2 cells and more prominent cytotoxicity compared with W198-untreated group on 4T1 cells. The oral bioavailability of W198/PTX micelles group was nearly 5.7-folds higher than the PTX micelles only group. In addition, W198/PTX micelles showed enhanced anticancer efficacy., Conclusions: We established a multistage oral delivery system to improve oral bioavailability and anticancer efficacy of PTX.
- Published
- 2021
- Full Text
- View/download PDF